| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5574264 | Journal of Stroke and Cerebrovascular Diseases | 2017 | 7 Pages |
Abstract
Nearly half of patients with cancer and stroke die within 3 months, and functional outcome is poor for 50% of 3-month survivors despite consideration of acute stroke treatment. Future research should address the role of hypercoagulability in the outcome prediction of stroke patients with cancer.
Related Topics
Health Sciences
Medicine and Dentistry
Clinical Neurology
Authors
Shawna MD, MS, Meagan MD, James J. MD, MS, Bichun PhD, Katharina MD, MS,